This site is new - feedback and suggestions welcome via GitHub issues.
0

Natural ligand-based CAR T-cell therapy targeting BCMA and TACI for relapsed or refractory multiple myeloma (TriPRIL): a non-randomised, phase 1, first-in-human trial. (linkinghub.elsevier.com)

Authors: Puliafito BR … Maus MV Journal: The Lancet Published: 2026-11-17 DOI: https://doi.org/10.1016/S0140-6736(26)01806-4
submitted by robot 2d ago 0 comments

Comments

No comments yet. Be the first!